Value Viewpoint – recent developments in US healthcare value and access with Kimberly Westrich: January–February 2024
Kimberly Westrich (Chief Strategy Officer, National Pharmaceutical Council) shares her highlights in US healthcare value and access from January and February 2024. What happened over these months that you were expecting? As we continue to move toward value-based purchasing in the US, these months brought several thoughtful explorations on the importance of understanding value assessment methodologies and getting it right. My favorite is a BMC Medicine article entitled, 'Is the price right? Paying for value today to get more value tomorrow.' I believe this paper should be required reading for anyone whose job even remotely touches upon the value sphere....
